Cipla Ltd share price
Cipla Ltd (CIPLA) is a stock listed on India's exchanges (NSE & BSE). It is commonly tracked under the Pharma theme. As of the latest filings, Cipla Ltd has a return on equity (ROE) of 11.60%, return on capital employed (ROCE) of 15.50%, a price-to-earnings (P/E) ratio of 35.90 and a debt-to-equity ratio of 0.02. On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal โ which star investors hold it and who is buying it on today's bulk/block deals tape.
Key fundamentals
Source: screener.in (NSE/BSE filings) ยท Fundamentals as of 02 Nov 2026 ยท figures from the latest annual & quarterly filings. Not investment advice.
Cipla Limited value chain โ customers, suppliers & competitors
Cipla Limited manufactures and sells branded and generic pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) globally. It sits in the middle of the healthcare value chain, buying raw inputs to produce medicines sold to hospitals, distributors, and retail consumers.
๐ Customers โ who buys from Cipla Limited
- Hospitals and Healthcare Institutions โ Prescription drugs and specialized hospital formulations
- Distributors and Pharmacies โ Over-the-counter and trade generic medicines
โ๏ธ Suppliers โ raw materials & inputs
- Active Pharmaceutical Ingredients (APIs) โ Chemical compounds and raw drug materials
- Excipients and Packaging Materials โ Binders, fillers, vials, and blister packs
โ๏ธ Competitors โ other sellers
- Dr. Reddy's Laboratories โ Competes in global generic formulations and active pharmaceutical ingredients, with a strong US presence.
- Lupin โ Rivals in cardiovascular, respiratory, and anti-infective drug segments globally.
- Torrent Pharmaceuticals โ Competes closely in the domestic branded prescription drug market.
๐ Other suppliers to its customers
- Sun Pharmaceutical Industries โ Largest Indian pharma player supplying alternative generic drugs and formulations to pharmacies and hospitals.
๐ค Peers that share its suppliers
- Sun Pharmaceutical Industries โ Buys similar specialty chemical raw materials and APIs from common domestic and global vendors.
This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.